The Pivot When Changing Direction Goes Wrong

Did you know a multi-billion dollar startup once tried to revolutionize healthcare using a repurposed glue-dispensing robot? A startup pivot is often celebrated as the ultimate entrepreneurial move, but it's frequently used to mask deep-seated failure. When a company's original vision hits a wall, the decision to change direction must be based on a new truth, not a convenient lie.

What is The Pivot?

A pivot is a fundamental change in business strategy. In the book Bad Blood, author John Carreyrou describes how Theranos founder Elizabeth Holmes shifted her company's entire focus once her initial idea failed. The concept involves recognizing that a current product or market isn't working and redirecting resources toward a more viable path. In the real world, this matters because burning through capital on a broken model is the fastest way to kill a company.

Core Components

Avoiding Sunk Costs during a Startup Pivot

Entrepreneurs often fall in love with their first idea and refuse to let go. This creates a psychological trap where they keep throwing money at a failing vision because they've already spent so much. A successful change in direction requires an honest audit of what's actually possible versus what's merely aspirational. Theranos spent its first $6 million on a "microfluidic patch" that turned out to be science fiction before finally moving on.

Validating Technical Feasibility Early

You can't pivot to a new strategy if the underlying technology doesn't exist. It's easy to draw a diagram on a whiteboard, but the physics of the product must work in the lab. Theranos ignored this, trying to shrink a lab into a box without solving the basic problems of fluid contamination. According to the book, the company's engineers spent months testing food coloring in cartridges because they couldn't get real blood to flow correctly.

Managing Ethics during Product Iteration

Effective product iteration means improving a version that already has a solid foundation. It's not a license to fake results while you wait for the technology to catch up. When the original patch failed, the company pivoted to the "Edison" device, which was essentially a modified glue-dispensing robot. The pressure to succeed led to faked demonstrations, such as the one for Novartis where the team beamed fake results to Switzerland to hide a hardware crash.

Maintaining Transparency with Stakeholders

A pivot should be an open conversation with investors and board members. Hiding the shift suggests that the new direction is a cover-up rather than a strategy. Elizabeth Holmes kept her board in the dark about the move to the "Edison," even as she used it to pitch new funding rounds. The book notes that Theranos eventually raised $400 million at a $9 billion valuation, largely based on technology that was a desperate, untested pivot.

Real-World Examples

The most infamous example is the Theranos shift to the "gluebot." After realizing the microfluidic patch was impossible, Tony Nugent built a prototype using a $3,000 robot from New Jersey. It used a robotic arm to mimic the actions of a human chemist. While it was more reliable than the patch, it was still far from a finished product.

Another example involves the 2006 Novartis demonstration. When the device malfunctioned in Basel, the team in California sent a fake result to Elizabeth's laptop to save the deal. This wasn't an iteration; it was a fraud designed to buy time for a failing pivot. The company claimed it had deals worth up to $300 million with five different pharmaceutical giants, yet many of these partners eventually walked away when the data didn't hold up.

Making a Successful Business Strategy Change

1. Conduct a brutal honesty audit. Ask your engineering team if the current product can realistically meet the market's needs within your remaining budget. If the answer is no, stop spending and start looking for a pivot point that uses your existing assets without requiring a miracle.

2. Set a definitive kill date. Decide exactly when you'll stop working on the old model to prevent the sunk cost fallacy from draining your accounts. At Theranos, the pivot was delayed because the founder was fixated on a 10-microliter blood sample that was physically too small to test accurately.

3. Re-validate with outside experts. Once you pivot to a new model, have it checked by someone who doesn't report to you. This prevents the echo chamber that allowed the "Edison" to be marketed as a breakthrough when it was just a converted industrial tool.

Why Failing Fast is a Dangerous Cliché

Silicon Valley culture encourages founders to "fail fast" and pivot often. However, critics argue this mindset is dangerous in high-stakes industries like medicine or finance. In Bad Blood, we see how the "fake it until you make it" attitude leads to ethical compromises. Some experts believe that a startup pivot shouldn't be a way to avoid the consequences of a bad idea, but a structured move toward a proven market need. Pivoting into a lie doesn't save a business; it just delays its funeral.

Theranos proved that a pivot is only as good as the truth behind it. Changing direction isn't a failure, but doing so without a working product is a recipe for disaster. Stop refining a broken vision and demand a working prototype before you scale your next move.